MedTrace Logo

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

NCT06449937 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-06-10

No results posted yet for this study

Summary

The purpose of this study was to investigate the effect of only local radical treatment of liver metastases combined with systematic treatment in the treatment of patients with multiple organ metastases of colorectal cancer, whether it can benefit the prognosis and explore the risk factors related to the prognosis.

Conditions

  • Metastatic Colorectal Carcinoma
  • Multi-organ Metastatic Colorectal Cancer
  • Metastatic Malignant Neoplasm in the Liver

Interventions

PROCEDURE

Radical local Surgery

Radical local resection of liver metastases ( hepatectomy, ablation )

DRUG

Systemic therapy

Chemotherapy, targeted drug therapy, immunotherapy treatment.

OTHER

Interventional therapy

Transcatheter arterial chemoembolization (TACE) Hepatic arterial infusion chemotherapy (HAIC)

Sponsors & Collaborators

  • First Affiliated Hospital of Wannan Medical College

    collaborator OTHER

  • Anhui Provincial Hospital

    lead OTHER_GOV

Principal Investigators

  • Ji-Zhou Wang, MD PhD · Anhui province hospital

  • Xiao-Ming Wang, MD PhD · First Affiliated Hospital of Wannan Medical College

  • Yu-Zhi Hu, MD · The Second People's Hospital of Wuhu

  • Yi-Ming Cao, MD · Ma'anshan People's Hospital

  • Qing-Song Yang, MD · The First People's Hospital of Chu Zhou

  • Si-Hua Wu, MD · Fuyang Cancer Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06449937 on ClinicalTrials.gov